Open Trials - Recruiting - TROG Cancer Research

TROG 21.12 – ASPIRE

Australian Particle Therapy Clinical Quality Registry

TROG 18.01 – NINJA

Novel Integration of New prostate radiation therapy schedules with adJuvant Androgen deprivation

TROG 18.06 – FIG

Prospective, multicentre trial evaluating FET-PET in Glioblastoma

TROG 19.06 – DECREASE

DarolutamidE + Consolidation Radiotherapy in Advanced prostate cancer detected by PSMA

TROG 21.07 – SOCRATES HCC

A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HCC

AGITG/TROG 21.03 – RESOLUTE

Randomised Phase II Trial to Evaluate the Strategy of Integrating Local Ablative Therapy with First-Line Systemic Treatment for Unresectable Oligometastatic Colorectal Cancer

AGITG/TROG 18.04 – MASTERPLAN

A Randomised Phase II Study of MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease

ANZ 1601/BIG 16-02/TROG 16.04 – EXPERT

Examining Personalised Radiation Therapy for Low-risk Early Breast Cancer

ANZGOG/TROG 21.04 – ADELE

ADjuvant tislelizumab plus chemotherapy after post-operative pelvic chemoradiation in high risk EndometriaL cancer (ADELE): a randomised phase 2 trial

MASC 03.18/TROG 21.01 – I-MAT

A randomised, placebo-controlled, Phase II trial of adjuvant Avelumab in patients with stage I-III Merkel cell carcinoma

SEAFARER

RTQA: Sensitivity Assessment System to Improve Quality in Radiation Oncology Treatment (SEAFARER)

VESPA

RTQA: Virtual EPID Standard Phantom Audit

Open Trials – Recruiting